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Review Article
Genetic Risk Factors in Male Infertility
Csilla Krausz
and Claudia Giachini
Andrology Unit, Department of
Clinical Physiopathology, Viale
Pieraccini, 6, Firenze, Italy
The etiopathogenesis of testicular failure remains unknown in about half of
the cases and is referred to as ‘‘idiopathic infertility’’. ‘‘Idiopathic’’ testicular
failure is of probable genetic origin since the number of genes involved in
human spermatogenesis is likely thousands and only a small proportion of
them have been identified and screened in infertile men. In parallel with stu-
dies aimed to identify mutations with a clear cause-effect relationship in
spermatogenesis candidate genes, there is an increasing interest towards
genetic susceptibility factors to male infertility. Despite many efforts, only
a few clinically relevant polymorphisms have been identified. This is mainly
related to the multifactorial nature of male infertility and to the inappropriate
study design of the majority of the studies. The most promising polymorph-
isms are in genes involved in the endocrine regulation of spermatogenesis
and on the Y chromosome, the ‘‘gr=gr’’ deletions. Polymorphisms are gen-
erally considered as co-factors. Their final effect on testis function and fer-
tility is probably modulated by the genetic background of each individual
and=or by the presence of certain environmental factors. In this review,
recent findings concerning some of the most widely studied polymorphisms
and male infertility will be discussed.
KEYWORDS gene mutations, genetic risk factors, genetics, gr=gr deletions,
male infertility, polymorphisms, spermatogenesis
INTRODUCTION
There is an increased interest in using genetic markers like polymorph-
isms in all areas of medicine including male infertility. A genetic variant
may be directly responsible for a given phenotype if it affects the function
or expression of a protein or if it can be in linkage disequilibrium with a
functionally relevant mutation in the same or in another related gene. There-
fore, studies dealing with polymorphisms are not only important for identi-
fying genetic ‘‘risk factors,’’ but they may also represent an important starting
point for searching for genes involved in a given disease through linkage
analysis. The identification of functionally relevant polymorphisms are also
important from a pharmacogenomic point of view and will be probably
used in the future for personalized therapies. In this review recent findings
concerning some of the most extensively studied polymorphisms and male
infertility will be discussed.
Abbreviations: AR: Androgenic
Receptor; ERS: Estrogenic Receptor;
FSHR: Follicle-Stimulating Hormone
Receptor; TA; SNP12
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Until now, the most widely used approach for the
study of haplogroups, allele variants, and single nucleo-
tide polymorphisms in male infertility were based on
case control studies. Formany genes only sporadic data
are available, or, when more studies are published on
the same polymorphism results are often contradictory
(Table 1). The question arises, how do we resolve this
sometimes seemingly contradictory data?
POLYMORPHISMS IN GENES
INVOLVED IN THE ENDOCRINE
REGULATION OF SPERMATOGENESIS
The crucial role of androgens, gonadotropins and
estrogens in the endocrine regulation of spermato-
genesis is well known, thus the genes of their recep-
tors represent a logical target for mutational analysis
in the infertile male.
The androgen receptor (AR) is a ligand activated
transcription factor which is encoded by the AR gene
located on the long arm of the X chromosome
(Xq11-q12). The AR gene has been the object of a
large quantity of studies, and both mutation screen-
ings of the entire coding sequence and the promoter
region have been reported [Yong et al. 2003]. The
first exon of the AR codes for the transactivation reg-
ulating domain and contains two polymorphic tracts,
a CAG and a GGC repeat sequence. The polymor-
phic (CAG)n codes for polyglutamine whereas the
(GGC)n repeat for polyglicine. It has been demon-
strated in vitro for the (CAG)n repeats that the length
of the polyglutamine tract, while remaining within
the polymorphic range, is inversely correlated with
the transactivation activity of the receptor [Tut et al.
1997]. Concerning the (GGC)n repeat a recent report
showed that ARs with GGN repeat, lengths other
than the most common one of 23, have a lower trans-
activating capacity [Lundin et al. 2007].
As expected from early in vitro studies, CAG repeat
length and male infertility have shown a significant
association between relatively long CAG repeats and
impaired sperm production. However, subsequent
TABLE 1 Summary of Case Control Association Studies of Different Polymorphisms in Genes or in DNA Sequences
with Potential Effect on Spermatogenesis
Case Control Studies
Polymorphism More than one study Single study
& in GENES involved in:
Endocrine regulation of
spermatogenesis
AR CYP19A1
FSHR NRIP1
ESR1
ESR2
Specific spermatogenic
functions
DAZL GRTH
PRM1–PRM2 CREM–ACT
TNP1–TNP2 KIT–KITLG
USP26
Common cell functions
(metabolism, cell cycle,
mutation repair)
POLG GSTM1
MTHFR PHGPx
BRCA2
MS
MTRR
APOB
& in DNA sequences: Y-chromosome haplogroups
‘‘gr=gr’’ deletions
Mitochondrial DNA
haplogroups
Abbreviations: ACT: activator of CREM in the testis; APOB: apolipoprotein B; AR: Androgen Receptor; BRCA: Breast Cancer;
CREM: cAMP-Responsive Element Modulator; CYP19A1: CYP19 aromatase; DAZL: Deleted Azoospermia-Like; ESR: Estrogen
Receptor; FSHR: Follicle-Stimulating Hormone Receptor; GRTH: Gonadotrophin-Regulated Testicular Helicase; GSTM1: Glutathione
S-Transferase M1; KIT: v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; KITLG: KIT Ligand; MS: methionine
synthase;MTHFR: 5,10-MethyleneTetraHydroFolate Reductase; GSTM1: Glutathione S-transferase M1; PHGPx: Phospholipid Hydro-
peroxide Glutathione Peroxidase; MTRR: MS Reductase; NRIP: nuclear receptor interacting protein; POLG: mitochondrial DNA
gamma-polymerase; PRM: Protamine; TNP: Transition Nuclear Protein; USP26: Ubiquitin Specific Peptidase 26.
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studies gave rather contradictory results. This in part
can be the consequence of ethnic differences (the
association seems to be more consistent in the Asiatic
populations) although the heterogenicity of the con-
trol (unselected men or proven fertile men or normos-
permic men) and of the infertile (different inclusion
criteria) groups [for review see Krausz et al. 2004a
and references therein] may also play an important
role [for review see Asatiani et al. 2003 and references
therein].
Similarly, there is no clear agreement about the
effect of GGC repeat length and sperm production.
Recently, two European groups attempted to evaluate
the joint effect of both exon 1 polymorphic microsatel-
lites on male infertility [Ferlin et al. 2004; Ruhayel et al.
2004], but the ‘‘protective’’ and ‘‘at risk’’ CAG=GGC
haplotypes were different in the two Caucasian popu-
lations. Due to these discordant association data and to
the lack of in vitro expression studies on the effect of
varying GGC length in combination with different
CAG repeats, the clinical utility of the CAG=GGC hap-
lotype definition remains unclear.
In summary, if only data based on large study
populations are considered, the CAG repeat length
polymorphism is an unlikely risk factor for male
infertility. However, its role in modulating androgen
action is evident in patients affected by Klinefelter’s
syndrome [Lanfranco et al. 2004], in hypogonadal
men undergoing T replacement therapy [Zitzmann
et al. 2004] and in hypoandrogenic males [Canale
et al. 2005]. It is therefore possible that the mild func-
tional effect of a long polyglutamine stretch can be
compensated by a relatively high serum testosterone
level, ergo the polymorphism should not be evalu-
ated in isolation but always in the context of environ-
mental factors. Moreover, the analysis of CAG repeat
length could be useful for personalized substitutive
testosterone therapy.
Although the physiological role of estrogens in
spermatogenesis is not clearly defined, human and
animal models exhibit an association between estro-
gen insufficiency and abnormal spermatogenesis.
While recent studies suggest a role as a survival fac-
tor [Pentikainen et al. 2000], the excess of this hor-
mone during the neonatal period or adulthood can
impair sperm production in rats [Atanassova et al.
2000]. The physiological responses to estrogens
are known to be mediated by at least two functional
isoforms of estrogen receptors (ER), i.e., ERalpha
(ESR1) and ERbeta (ESR2), encoded by two different
genes on different chromosomes (6q25 and 14q23-
24, respectively). Apart from estradiol, other com-
pounds with estrogen-like activity (xenoestrogens)
may bind to ERs and may account for the reported
decline in sperm count as well as for the increased
incidence of other components of the testicular dys-
genesis syndrome—hypospadias, cryptorchidism,
and testicular cancer—observed in the last 50 years
[Sharpe and Skakkebaek 1993].
Genetic screening of the ESR1 and ESR2 genes has
revealed the existence of several polymorphic sites
in both genes and some have been the object of male
infertility association studies [Kukuvitis et al. 2002;
Suzuki et al. 2002; Galan et al. 2005; Guarducci et al.
2006]. In the ESR1 gene, the most promising polymor-
phism is the (TA)n variable number of tandem repeats
(VNTR) within the promoter region. The distribution
of TA genotype is not different between controls and
patients. This polymorphism cannot be considered a
risk factor for male infertility. However, it has a signifi-
cant effect on sperm output both in normospemic and
infertile men [Guarducci et al. 2006]. The number of TA
repeats showed a significant inverse correlation with
sperm count and consequently men with a higher TA
repeat length on both alleles have significantly lower
sperm production. Since previous studies on lumbar
bone mineral density observed that allelic combinations
with a higher number of TA repeats are functionally
more active [Becherini et al. 2000], our finding indicates
that allelic combinations which confer a stronger estro-
gen effect may negatively influence human spermato-
genesis. A plausible explanation would be that in
addition to a deficit of estrogens there is an exaggerated
estrogen action related to this genetic variant, that when
combined with environmental factors, can be deleteri-
ous. Whether the observed negative effect reflects the
expression of a disturbance in early testis development
or in the adult testis and whether it is related to xenoes-
trogens remain to be established.
A specific haplotype AGATA, resulting from the
allelic combination of five SNPs situated in a 50 Kb
haplotype block of the ESR1, has been reported
as a risk factor for cryptorchidism in the Japanese
population [Yoshida et al. 2005]. We analyzed the
AGATA haplotype in the Spanish and Italian infertile
and control populations and found no association
between SNP12 (the tag SNP for the AGATA
haplotype) and infertility [Galan et al. 2007].
127 Polymorphisms of Male Infertility
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Surprisingly, we found a significant protective effect
for ESR1 SNP12 on cryptorchidism in the Italian popu-
lation. The discrepancy between our studies may be
related to genuine ethnic differences and=or different
environmental conditions.
To date, only two association studies evaluated the
role of ESR2 gene SNPs in male infertility [Aschim et al.
2005; Galan et al. 2005]. In one study the frequency of
the heterozygous RsaI AG-genotype was three times
higher in infertile men than in controls, indicating that
this polymorphism may have modulating effects on
spermatogenesis [Aschim et al. 2005]. In the other
study by Galan et al. [2005] no significant association
was found between another ESR2 SNP and infertility.
However, the authors detected genetic interaction
between five estrogen related gene markers identify-
ing a set of protective predisposing haplotypes.
In summary, preliminary data suggest that ESR1
and ESR2 polymorphisms may influence male fer-
tility, spermatogenic efficiency, and cryptorchidism.
It will be of interest to verify the effect of these ER
polymorphisms on spermatogenic potential in a
selected group of subjects with different grades of
exposure to xenoestrogens.
Follicle-stimulating hormone (FSH) the specific
receptor (FSHR) consists of 10 exons, also plays an
important role in spermatogenisis located on chromo-
some 2 (2p21-p16). Mutation screening of the FSHR
gene revealed three relevant single nucleotide poly-
morphisms (SNPs), the SNP in the core promoter at
position 29 and two others situated in exon 10 that
correspond to amino acid position 307 and 680,
respectively [for review see Gromoll and Simoni
2005]. A study of the distribution of the SNPs in normal
and infertile men reported that the combination of the
exon 10 SNPs with the  29 SNP can be considered as
a new genetic factor for severe spermatogenic impair-
ment [Ahda et al. 2005]. However, a recent report on
the Italian population was not able to identify a predis-
posing effect of the combined exon 10 SNPs and the
29 SNP [Pengo et al. 2006]. Given these discordances
further studies are needed to clarify this issue.
EXAMPLE OF POLYMORPHISMS IN
CANDIDATE AUTOSOMAL
SPERMATOGENESIS GENES
A number of spermatogenesis autosomal candidate
genes have been identified and they represent the
most obvious targets for mutation analysis [Stouffs
et al. 2005; A et al. 2006; Galan et al. 2006]. As
reported in Table 1, results are often contradictory
when more than one study is available. A remarkable
ethnic difference has been found for the T54A DAZL
gene polymorphism. The DAZL gene is an autosomal
homologue of the Y chromosomal DAZ (deleted in
azoospermia) gene cluster and is located on chromo-
some 3p24 [Yen et al. 1996]. DAZ and DAZL, together
with BOULE, are members of the same family and
encode RNA binding proteins with an important role
in spermatogenesis [Yen 2004]. The T54A variant in
the DAZL gene was reported as a susceptibility factor
to oligo=azoospermia in the Chinese population [Teng
et al. 2002]. This SNP is localized within the highly con-
served RNA-recognitionmotif domain of theDAZL pro-
tein and it may lead to functional consequences such as
reduced RNA binding. Despite this promising finding,
subsequent studies in Caucasian populations [Becherini
et al. 2004; Tschanter et al. 2004; Bartoloni et al. 2004]
and in the Japanese population [Yang et al. 2005] failed
to detect the T54Amutation inmore than 900men. This
strongly contrasts the relatively high frequency of this
mutation (7.4%) in the Chinese patients.
The Protamine1 and 2 (PRM1 and PRM2) genes
were the object of several studies [Tanaka et al.
2003; Miyagawa et al. 2005; Iguchi et al. 2006; Aoki
et al. 2006] which finally lead to the conclusion that
PRM1 polymorphism is probably relevant in a spe-
cific subset of patients. Since aberrations in the ratio
PRM1=PRM2 are associated with human male infer-
tility [for references see Aoki et al. 2006] it is expected
that the ratio of anomalies can be related to muta-
tions in genes involved in the chromatin compaction
such as PRM1, PRM2, TNP1 and TNP2. According to
this hypothesis, Carrell and his group [Aoki et al.
2006] screened for alterations in the genes encoding
PRM1, PRM2, TNP1 and TNP2 in a population of
idiopathic infertile men and a highly selected group
of patients with aberrations in the PRM1=PRM2 ratio.
The frequency of the 15 identified SNPs was similar
in the protamine-deficient patients, severely infertile
patient and fertile controls, indicating an unlikely
role for these variants for protamine deficiency. A
study on normospermic men with high sperm DNA
fragmentation (similar to the sperm derived from
protamine deficient mice) found a mutation G197T
in the PRM-1 gene which was specific for this highly
selected group of subjects [Iguchi et al. 2006].
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Products of the CREM gene (on chromosome
10p11.1–12.1) are essential for the differentiation of
round spermatids into mature spermatozoa
[Sassone-Corsi 1995; Blendy et al. 1996; Nantel et al.
1996; Krausz and Sassone-Corsi 2005] and they are
regulated in part by an activator of CREM in the tes-
tis, ACT (6q16.1–16.3) which is expressed exclusively
in the testis. Both genes were objects of mutation
screening. CREM was analyzed in a specific group
of men with round spermatid arrest [Vouk et al.
2005]. In this pilot study a number of genetic changes
have been identified and it seems that certain pat-
terns of homozygous and heterozygous alterations
could exert pathological effects. A recent mutational
screening in the ACT gene reports specific ACT
haplotypes which show statistically significant differ-
ences between patients and controls suggesting a
potential effect of different allelic combinations on
spermatogenesis [Christensen et al. 2006].
Screening of a larger number of patients and con-
trols is required to elucidate whether the observed
combinations of genetic changes in the CREM and
ACT genes can reconcile some forms of male infertility.
EXAMPLES OF POLYMORPHISMS
IN GENES WITH COMMON
CELL FUNCTIONS
Studies of polymorphisms in genes involved in
common cell functions required for normal sperma-
togenesis [Zhoucun et al. 2006; Peterlin et al. 2006;
please see other references through text] are sum-
marized in Table 1. Among them, the role of mito-
chondrial DNA polymerase c (POLG) has been the
object of extensive debate in the last few years.
The mitochondrial DNA polymerase c (POLG) is
the sole polymerase for mitochondrial DNA
(mtDNA) and impaired activity of this protein leads
to mitochondrial dysfunction through accumulation
of mtDNA mutations. The gene maps to 15q24–
15q26 and its first exon contains a polyglutamine
tract encoded by a motif (CAG)10 CAACAGCAG
[Ropp and Copeland 1996]. The length of the CAG
repeat is polymorphic with a major allele at 10
repeats. Rovio and colleagues [2001] proposed an
association between the absence of the common 10
CAG allele and male infertility in a relatively small
group of infertile (n ¼ 99) and fertile (n ¼ 98) men.
Another study on the Danish population observed a
significantly higher frequency of homozygous not10
CAG repeat allele in a subgroup of men affected by
unexplained infertility, i.e. normal sperm count,
motility, andmorphology [Jensen et al. 2004]. However,
this conclusion was based on an interpretation bias i.e.,
the seven unexplained infertile men with the homo-
zygous not10=not10 CAG genotype were not normos-
permic, with the exception of one subject. When
appropriately calculated the frequency is 1=42
(2.38%) not 7=49 (14.3%) the no significant difference
with respect to the control fertile group (0.8%). Our
own study on the Italian population (n ¼ 385) found
no relationship between the polymorphic CAG repeat
in the POLG gene and idiopathicmale infertility [Krausz
et al. 2004b]. Subsequent studies in populations from
Europe [Aknin-Seifer et al. 2005; Brusco et al. 2006]
and New Zeland [Harris et al. 2006] further confirmed
our finding.
It is therefore clear that the POLG CAG polymor-
phism has no clinical significance for idiopathic or
‘‘unexplained’’ male infertility. It should also be clari-
fied if the length of the CAG tract has any functional
effect on the polymerase activity. This is required
before we can propose it as a possible genetic factor
for asthenozoospermia.
Some of the genes listed in Table 1 may have a role
in specific conditions. For example polymorphisms in
the glutathione S-transferase M1 (GSTM1) and Phos-
pholipid hydroperoxide glutathione peroxidase
(PHGPx) may be relevant under conditions of oxidat-
ive stress (for example varicocele) [Chen et al. 2002;
Maiorino et al. 2003]. Similarly, another gene polymor-
phism C677T in the methylenetetrahydrofolate
reductase (MTHFR) gene seems to have clinical rel-
evance only in specific environmental conditions
which are more common in Indian, African, and
Southeast Asian populations [Bezold et al. 2001; Ebisch
et al. 2003; Stuppia et al. 2003; Singh et al. 2005; Park
et al. 2005] characterized by low dietary intake of
folates. Two promising SNPs in genes involved in
the folate metabolism were also proposed recently
in the Korean population [Lee et al. 2006]. Their role
in other geographic areas remains to be established.
Y CHROMOSOME POLYMORPHISMS:
THE ‘‘ggr/gr’’ DELETIONS
Apart from the classical AZF deletions, a new type
of Yq deletion has recently attracted the attention of
129 Polymorphisms of Male Infertility
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geneticists and andrologists. A partial deletion in the
AZFc region, termed ‘‘gr=gr’’ has been described
specifically in infertile men with varying degrees of
spermatogenic failure [Repping et al. 2003]. This
deletion removes half the AZFc gene content includ-
ing two copies of the major AZFc candidate gene
called DAZ [Reijo et al. 1995; Vogt et al. 2004]. In
the last two years an intensive search for ‘‘gr=gr’’
deletions in infertile and control men has started in
order to define their frequency and clinical signifi-
cance [Machev et al. 2004; de Llanos et al. 2005;
Ferlin et al. 2005; Giachini et al. 2005; Hucklenbroich
et al. 2005; Lynch et al. 2005; Ravel et al. 2006;
Carvalho et al. 2006]. Some of these studies reached
the conclusion that ‘‘gr=gr’’ deletions are significant
risk factors for oligo=azoospermia while other
studies did not find such an effect (Table 2).
The current method for the detection of ‘‘gr=gr’’
deletions is based on STS plus=minus PCR analysis.
This alone does not provide information about the type
of missing gene copies or deletion=duplication events.
The majority of ‘‘gr=gr’’ studies are lacking detailed
molecular analysis, i.e., the reduced gene dosage is
not confirmed and the type of deleted gene copies is
not known. These methodological differences together
with the inappropriate control selection (general popu-
lation or fertile controls with unknown sperm count)
may contribute to the contradictory results.
In contrast to the classical AZF deletions, ‘‘gr=gr’’
deletions can also be found in normospermic men.
We hypothesized a number of explanations for the
heterogeneous phenotype ranging from severe sper-
matogenic failure to normozoospermia: i) presence
of polymorphisms or mutations in the autosomal
homologue of the DAZ gene, DAZL; ii) dele-
tion=duplication events or other rearrangements that
could maintain the original gene dosage and conse-
quently would not affect spermatogenesis; iii) differ-
ences in the type of deleted AZFc gene copies and
iv) different Y chromosome background. In order
to verify these hypotheses, an accurate molecular
characterization of the deletions and DAZL gene
mutation screening was performed in our laboratory
[Giachini et al. 2005]. Our studies excluded a role for
DAZL gene mutations in the ‘‘gr=gr’’ phenotype,
whereas the effect and the frequency of dele-
tion=duplication events remains to be established.
The definition of the missing DAZ (1=2 or 3=4) and
CDY1 (a or b) copies allowed us to divide ‘‘gr=gr’’
deletions into different subtypes; two of them, which
remove CDY1a copy are specific and highly frequent
in patients, indicating that certain subtypes are more
pathogenic than others.
Consequently, a combined molecular characteri-
zation (haplogroup, gene dosage, and gene copy
type definition) of the ‘‘gr=gr’’ deleted patients and
controls will probably allow the distinction between
pathogenic and neutral deletions. Unfortunately, it is
impossible to perform a metaanalysis of the pub-
lished data due to methodological differences and
TABLE 2 Summary of ‘‘gr/gr’’ Deletion Case Control Studies with or without Association with Spermatogenic Disturbances
Patients Controls
Reference Population Tot n. gr=gr % Tot n. Normospermic % gr=gr % Gene Dosage
Positive Association
Repping et al. (2003) Dutch 246 3.7 148 100 0.0 yes
de Llanos et al. (2005) Spanish 283 4.2 232 14.6 0.0 no
Ferlin et al. (2005) Italian 337 5.3 263 100 0.4 no
Giachini et al. (2005) Italian 150 5.3 189 100 0.5 yes
Lynch et al. (2005) Australian 1351 4.1 234 57.3 0.4 no
No Association
Machev et al. (2004) French 300 6.0 399 1.2 3.5 yes
Hucklenbroich et al. (2005) German 348 4.0 170 100 1.8 no
Ravel et al. (2006) Mixed 192 2.1 181 8.8 3.3 no
Carvalho et al. (2006) Brazilian 110 4.5 240 0.0 2.9 no
Ethnic=geographic origin and the size of the study population is reported. Since the inclusion criteria for controls was different in different studies (gen-
eral population or proven fertile men with unknown sperm count, normospemic men), the percentage of normospermic men in each control group is
indicated. The frequency of ‘‘gr=gr’’ deletions in patients and controls are shown separately. Gene dosage was performed in only 3=9 studies in order
to confirm the deletions and exclude deletion=duplication events.
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different inclusion criteria of the controls. However, on
the basis of our own data from almost 800 subjects, we
can safely conclude that ‘‘gr=gr’’ deletions are a highly
significant risk factor (p < 0.001) for oligozoospermia.
Consequently, the screening for ‘‘gr=gr’’ deletions can
be advised to patients attending for assisted repro-
ductive techniques, since this test is able to provide
the identification of a transmissible genetic risk factor
for reduced sperm count.
CONCLUSIONS
Despite a generalized enthusiasm towards the
analysis of polymorphisms in genes affecting sper-
matogenesis, to date, only a few clinically relevant
polymorphisms have been identified. We often face
frustration when initial promising data are not con-
firmed in later studies. Discrepancies between
association studies are rather frequent and mainly
related to small sample size (especially when sub-
jects are further divided into subgroups according
to different allelic combinations) and to the use of
inappropriate control groups. In the majority of
studies, controls are subjects from the general popu-
lation or selected only on the basis of their fertility
with unknown sperm parameters. If the expected
effect of a polymorphism is spermatogenic disturb-
ance, the correct control group should be normos-
permic men. If the polymorphism is predicted to
influence the fertilization capacity, the most appro-
priate control should be proven fertile men. The
most evident examples supporting the importance
of normospemic controls and of the appropriate size
of the study population are ‘‘gr=gr’’ deletions and the
POLG studies. Selection of controls along with the
appropriate ‘‘cases’’ are crucial, especially if the gene
defect is expected to lead to a specific testicular
phenotype. Certain gene variants may cause specific
phenotypes (for example PRM1 and CREM) and
consequently it can be expected that only the analy-
sis of a specific subgroup of patients will be able to
identify their clinical significance.
Apart from the sample size and selection bias,
genuine ethnic and geographic differences can also
contribute to the lack of confirmation of results in
different populations. The recently described DAZL
gene polymorphism or the SNP12 in ESR1 represent
remarkable examples of ethnic differences [Becherini
et al. 2004; Galan et al. 2006].
Since polymorphisms are generally considered as
risk factors, their final effect on spermatogenesis is
probably modulated by additional factors such as
genetic background or environment. Considering
the multitude of factors and biases which can affect
the outcome of a case=control study, it is not surpris-
ing that published data are so contradictory. Large
scale multicenter and multiethnic studies with mul-
tiple markers (using a complex trait model) are
needed in order to identify reliable risk factors for
spermatogenic disturbances or for male infertility.
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